SNA-XFSb

**SNA-XFSb** is a proprietary specific nucleic acid component used in Labo'Life's sequential micro-immunotherapy product **2LXFS**. It is not a separately marketed medicine or a molecular entity with a publicly disclosed sequence, target, or pharmacologic mechanism. In 2LXFS, SNA-XFSb is supplied in homeopathic dilutions of 10 CH or 18 CH alongside SNA-XFSa, SNA-XFSc, cytokines, DNA, and RNA. The 2LXFS product is administered as sublingual globules in numbered capsules. A Phase IV study is evaluating 2LXFS for asthenia in patients with Epstein-Barr virus infection; however, the individual contribution of SNA-XFSb has not been clinically isolated. Spanish product information classifies 2LXFS as a homeopathic medicine without approved therapeutic indications.

Other names

Specific Nucleic Acid SNA-XFSbSpecific Nucleic Acid – Chronic Fatigue Syndrome Cytomegalovirus